It appears you don't have support to open PDFs in this web browser. To view this file, Open with your PDF reader
Abstract
Layer-by-layer (LbL) deposition method of polyelectrolytes is a versatile way of developing functional nanoscale coatings. Even though the mechanisms of LbL film development are well-established, currently there are no predictive models that can link film components with their final properties. The current health crisis has shown the importance of accelerated development of biomedical solutions such as antiviral coatings, and the implementation of machine learning methodologies for coating development can enable achieving this. In this work, using literature data and newly generated experimental results, we first analyzed the relative impact of 23 coating parameters on the coating thickness. Next, a predictive model has been developed using aforementioned parameters and molecular descriptors of polymers from the DeepChem library. Model performance was limited because of insufficient number of data points in the training set, due to the scarce availability of data in the literature. Despite this limitation, we demonstrate, for the first time, utilization of machine learning for prediction of LbL coating properties. It can decrease the time necessary to obtain functional coating with desired properties, as well as decrease experimental costs and enable the fast first response to crisis situations (such as pandemics) where coatings can positively contribute. Besides coating thickness, which was selected as an output value in this study, machine learning approach can be potentially used to predict functional properties of multilayer coatings, e.g. biocompatibility, cell adhesive, antibacterial, antiviral or anti-inflammatory properties.
You have requested "on-the-fly" machine translation of selected content from our databases. This functionality is provided solely for your convenience and is in no way intended to replace human translation. Show full disclaimer
Neither ProQuest nor its licensors make any representations or warranties with respect to the translations. The translations are automatically generated "AS IS" and "AS AVAILABLE" and are not retained in our systems. PROQUEST AND ITS LICENSORS SPECIFICALLY DISCLAIM ANY AND ALL EXPRESS OR IMPLIED WARRANTIES, INCLUDING WITHOUT LIMITATION, ANY WARRANTIES FOR AVAILABILITY, ACCURACY, TIMELINESS, COMPLETENESS, NON-INFRINGMENT, MERCHANTABILITY OR FITNESS FOR A PARTICULAR PURPOSE. Your use of the translations is subject to all use restrictions contained in your Electronic Products License Agreement and by using the translation functionality you agree to forgo any and all claims against ProQuest or its licensors for your use of the translation functionality and any output derived there from. Hide full disclaimer
Details
1 Centre de Recherche en Biomédecine de Strasbourg, Inserm UMR_S 1121, Biomaterials and Bioengineering, Strasbourg, France (GRID:grid.7429.8) (ISNI:0000000121866389); Faculté de Chirurgie Dentaire, Université de Strasbourg, Strasbourg, France (GRID:grid.11843.3f) (ISNI:0000 0001 2157 9291)
2 PRESTE, Paris, France (GRID:grid.11843.3f)
3 SPARTHA Medical, Strasbourg, France (GRID:grid.11843.3f)
4 Centre de Recherche en Biomédecine de Strasbourg, Inserm UMR_S 1121, Biomaterials and Bioengineering, Strasbourg, France (GRID:grid.7429.8) (ISNI:0000000121866389); Faculté de Chirurgie Dentaire, Université de Strasbourg, Strasbourg, France (GRID:grid.11843.3f) (ISNI:0000 0001 2157 9291); SPARTHA Medical, Strasbourg, France (GRID:grid.11843.3f)